Illumina DNA Sequencing Systems

Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The company was founded in San Diego, California, in 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee. Since its inception, Illumina has transitioned from a small start-up to a dominant force in the genomics industry, significantly lowering the cost of sequencing the human genome through its innovative Next-Generation Sequencing (NGS) platforms.

Manufacturing for Illumina's high-tech hardware and chemical reagents is primarily concentrated in the United States and Singapore, ensuring a robust supply chain for laboratories worldwide. The brand remains an independent, publicly traded entity, maintaining its headquarters in San Diego. As of 2024 and looking toward 2026, Illumina continues to operate as the ultimate owner of its brand and core subsidiaries, focusing on expanding the accessibility of genomic data to improve human health.